Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Social barriers were linked to reduced access and low uptake of LAI PrEP and ART for HIV treatment and prevention.

Kennedy publicly questioned several aspects of the HIV epidemic, including whether the virus causes AIDS. He has promoted the idea that AIDS could be caused by the recreational drug poppers ...

A small French biotech is trumpeting results from a trial suggesting its developmental drug ... with HIV infection received 150mg ABX464 for 28 days in addition to their antiretroviral treatment.

Apr. 9, 2025 — This handheld device is the first that can detect tuberculosis in saliva, in addition to blood and sputum samples, an important breakthrough for testing children and HIV patients ...

The prevalence of hepatitis C virus (HCV) has decreased over time among patients with HIV infection in the United States with the use of direct-acting antiviral (DAA) therapy, according to findings ...

French biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment. The company ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...